Jiangsu Hansoh Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ENZALUTAMIDE, with a corresponding US DMF Number 39853.
Remarkably, this DMF maintains an Active status since its submission on September 04, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 18, 2024, and payment made on August 21, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II